Rosetta Genomics’ David Sidransky Quits as Director

Wednesday, 22 November 2017 04:03
Rate this item
(0 votes)

Dr. David Sidransky, M.D., notified Rosetta Genomics Ltd. that he was resigning as a director, effective Nov. 13, 2017, due to other professional obligations. Dr. Sidransky's resignation from the Boards of Directors did not result from any disagreement with the Company, the Company's management or the Board of Directors, according to a Form 6-K report filed with the U.S. Securities and Exchange Commission.

Please log in or register to view the entire article

Related items (by tag)

back to top
telefon dinleme